Hennion & Walsh Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
24,396
-15,561
| -39% | -$757K | 0.05% | 456 |
|
|
2025
Q1 | $1.36M | Sell |
39,957
-4,348
| -10% | -$148K | 0.06% | 389 |
|
|
2024
Q4 | $1.74M | Buy |
44,305
+3,737
| +9% | +$147K | 0.08% | 319 |
|
|
2024
Q3 | $1.91M | Buy |
40,568
+5,567
| +16% | +$262K | 0.09% | 290 |
|
|
2024
Q2 | $1.89M | Buy |
35,001
+18,125
| +107% | +$979K | 0.1% | 259 |
|
|
2024
Q1 | $1.15M | Buy |
16,876
+411
| +2% | +$28K | 0.06% | 390 |
|
|
2023
Q4 | $1.03M | Buy |
16,465
+1,150
| +8% | +$72K | 0.06% | 399 |
|
|
2023
Q3 | $695K | Buy |
15,315
+7,235
| +90% | +$328K | 0.04% | 440 |
|
|
2023
Q2 | $454K | Buy |
+8,080
| New | +$454K | 0.03% | 533 |
|